Loading organizations...
Moxe Health develops solutions that streamline the secure exchange of clinical data, fostering collaboration and efficient operations between healthcare payers and providers. Its core offering, the Clinical Data Clearinghouse, acts as an intermediary to facilitate precise and timely information sharing, addressing the complex challenges associated with interoperability and the movement of health records. This approach aims to reduce administrative burdens and improve overall data utilization within the healthcare ecosystem.
The company was founded in 2012 by Dan Wilson, whose insight recognized the pervasive inefficiencies and friction points in how clinical information was shared across the healthcare landscape. Wilson aimed to address the fundamental need for a more integrated and less cumbersome process for data exchange, enabling stakeholders to access critical patient information swiftly and securely without traditional manual or fragmented methods.
Moxe Health serves both providers, by managing release of information, and payers, by enabling efficient clinical data exchange. Its vision centers on connecting the healthcare ecosystem through high-quality, efficient data, empowering stakeholders to transform raw data into actionable insights for improved payment, operations, and clinical outcomes. The company strives to eliminate barriers and simplify complex data challenges to foster meaningful collaboration across the industry.
Moxe Health has raised $35.8M across 3 funding rounds.
Moxe Health has raised $35.8M in total across 3 funding rounds.
Moxe Health is a healthcare technology company that builds a digital-first platform to securely exchange clinical data between providers and payers—automating chart retrieval and release-of-information workflows and delivering payer insights into the clinical workflow to support risk adjustment, quality, care management and payment integrity use cases[3][6].
High-Level Overview
Moxe Health provides a clinical data exchange platform that connects payers, providers, EHRs and national networks to deliver timely, usable clinical data and actionable insights into provider workflows, reducing manual ROI (release of information) work and administrative waste while improving documentation and decision-making for value-based programs[3][6][4]. Moxe serves health systems, hospitals, provider groups and health plans by offering EHR‑agnostic tools for digital ROI, chart retrieval, and a “convergence” capability that lets payer insights be presented in the EHR at point of care[6][5]. The company reports large-scale reach across its network (hundreds of thousands of providers and hundreds of health systems) and positions itself as a neutral interoperability partner enabling payers to get the minimum necessary, timely clinical data and providers to manage requests digitally[6][1][4].
Origin Story
Moxe’s public materials describe a company formed to solve the chronic friction of manual, paper‑based clinical data exchange by building a platform that directly connects to major EHRs and automates targeted data extraction and sharing[4][8]. The firm has raised growth capital to scale—public reporting cites a 2024 growth investment and earlier Series B rounds used to expand the team and advance the technology[5]. Executives quoted in press and the company site frame Moxe as evolving from automated ROI and chart retrieval into a broader platform that ingests heterogenous clinical data, contextualizes it, and delivers insights back into provider workflows—particularly in response to regulatory drivers like the 21st Century Cures Act[4][7].
Core Differentiators
Role in the Broader Tech Landscape
Moxe is riding the broader trends of regulatory pressure for interoperability (Cures Act/data‑sharing rules), payer-provider collaboration driven by value-based care, and the industry imperative to digitize and automate administrative workflows to lower costs and clinician burden[4][6]. Timing matters because regulators and market participants increasingly demand timely, computable clinical data and pragmatic ways to exchange it without exposing unnecessary information; Moxe’s focus on configurable, use‑case‑driven exchanges aligns with those market forces[4][1]. By enabling more efficient chart exchange and embedding payer insights into provider workflows, Moxe influences the ecosystem by lowering the friction for risk-adjustment, quality measurement and care management programs and by enabling payers and providers to operate on a common, digitized data foundation[6][5].
Quick Take & Future Outlook
Moxe’s near-term trajectory is likely to center on scaling its network, deepening EHR integrations, and productizing platform capabilities that turn ingested clinical data into standardized, actionable datasets for payer and provider use cases—especially as demand grows for automated ROI, risk-adjustment accuracy, and point-of-care decision support[7][6][5]. Key trends that will shape Moxe’s path include continued regulatory emphasis on interoperable access, expansion of value‑based contracting that requires high‑quality clinical data, and heightened focus on minimizing administrative costs in health care; success will hinge on maintaining neutrality, expanding coverage across EHRs and payers, and demonstrating measurable ROI for customers[4][6][7]. If Moxe continues scaling adoption and proving operational savings and better data quality, it can strengthen its role as a core infrastructure provider for payer-provider data exchange and a facilitator of more coordinated, data‑driven care[6][1].
If you want, I can produce a one‑page investor-style snapshot (key metrics, funding timeline, customers and risks) or extract specific citations and quotations from Moxe’s filings and press coverage.
Moxe Health has raised $35.8M across 3 funding rounds. Most recently, it raised $30.0M Series B in May 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2022 | $30M Series B | Vensana Capital, Thomas Schnettler | 3M Ventures, Apollo, Safeguard Scientifics, UPMC Enterprises | Announced |
| Oct 4, 2016 | $5.5M Series A | Gary Kurtzman, MD | — | Announced |
| Dec 1, 2012 | $300K Seed | — | HealthX Ventures | Announced |
Moxe Health has raised $35.8M in total across 3 funding rounds.
Moxe Health's investors include Vensana Capital, Thomas Schnettler, 3M Ventures, Apollo, Safeguard Scientifics, UPMC Enterprises, Gary Kurtzman, MD, HealthX Ventures.
